Sequent Scientific Limited (BOM: 512529)
179.85
+3.85 (2.19%)
At close: Sep 10, 2024
Sequent Scientific Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Revenue | 14,267 | 13,697 | 14,209 | 14,128 | 13,616 | 11,792 | Upgrade
|
Revenue Growth (YoY) | 0.99% | -3.60% | 0.57% | 3.76% | 15.47% | 13.46% | Upgrade
|
Cost of Revenue | 7,792 | 7,853 | 8,581 | 8,149 | 7,165 | 6,227 | Upgrade
|
Gross Profit | 6,475 | 5,845 | 5,628 | 5,979 | 6,451 | 5,566 | Upgrade
|
Selling, General & Admin | 2,485 | 2,548 | 2,618 | 2,334 | 1,883 | 1,657 | Upgrade
|
Other Operating Expenses | 2,816 | 2,448 | 2,605 | 2,547 | 2,344 | 2,126 | Upgrade
|
Operating Expenses | 5,936 | 5,612 | 5,781 | 5,400 | 4,763 | 4,313 | Upgrade
|
Operating Income | 539.22 | 232.73 | -153.46 | 579.62 | 1,688 | 1,252 | Upgrade
|
Interest Expense | -539.86 | -464.23 | -297.19 | -135.09 | -192.54 | -327.02 | Upgrade
|
Interest & Investment Income | - | 6.7 | 12.1 | 4.07 | 16.21 | 67.67 | Upgrade
|
Currency Exchange Gain (Loss) | - | -153.49 | -114.46 | 63.03 | -42.16 | -54.88 | Upgrade
|
Other Non Operating Income (Expenses) | 62.85 | 29.97 | -27.11 | 15.52 | -16.64 | -1.72 | Upgrade
|
EBT Excluding Unusual Items | 62.21 | -348.32 | -580.12 | 527.15 | 1,452 | 936.34 | Upgrade
|
Merger & Restructuring Charges | -47.08 | -228.14 | -421.76 | - | -38.26 | - | Upgrade
|
Impairment of Goodwill | - | - | -204.09 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | 0.17 | 0.51 | 3.18 | 25.79 | 3.65 | Upgrade
|
Gain (Loss) on Sale of Assets | 65.62 | 55.42 | 20.42 | -0.69 | 6.98 | 1.14 | Upgrade
|
Asset Writedown | - | -1.64 | -1.61 | -0.34 | -30.69 | -0.41 | Upgrade
|
Other Unusual Items | -31.08 | -108.21 | -189.93 | - | -49.97 | - | Upgrade
|
Pretax Income | 130.34 | -546.46 | -1,377 | 529.3 | 1,366 | 940.75 | Upgrade
|
Income Tax Expense | -10.93 | -250.33 | -156.81 | 81.66 | 321.77 | 120.29 | Upgrade
|
Earnings From Continuing Operations | 141.27 | -296.13 | -1,220 | 447.64 | 1,045 | 820.46 | Upgrade
|
Net Income to Company | 141.27 | -296.13 | -1,220 | 447.64 | 1,045 | 820.46 | Upgrade
|
Minority Interest in Earnings | -86.36 | -62.56 | 8.18 | -38.09 | -90.1 | -121.41 | Upgrade
|
Net Income | 54.91 | -358.69 | -1,212 | 409.55 | 954.42 | 699.05 | Upgrade
|
Net Income to Common | 54.91 | -358.69 | -1,212 | 409.55 | 954.42 | 699.05 | Upgrade
|
Net Income Growth | - | - | - | -57.09% | 36.53% | 43.66% | Upgrade
|
Shares Outstanding (Basic) | 249 | 249 | 248 | 247 | 247 | 243 | Upgrade
|
Shares Outstanding (Diluted) | 249 | 249 | 248 | 251 | 248 | 245 | Upgrade
|
Shares Change (YoY) | 0.45% | 0.06% | -0.90% | 1.15% | 1.04% | 0.54% | Upgrade
|
EPS (Basic) | 0.22 | -1.44 | -4.88 | 1.66 | 3.87 | 2.87 | Upgrade
|
EPS (Diluted) | 0.22 | -1.44 | -4.88 | 1.63 | 3.85 | 2.85 | Upgrade
|
EPS Growth | - | - | - | -57.66% | 35.09% | 43.22% | Upgrade
|
Free Cash Flow | - | -2.12 | -693.71 | -18.69 | 619.24 | 746.08 | Upgrade
|
Free Cash Flow Per Share | - | -0.01 | -2.79 | -0.07 | 2.50 | 3.04 | Upgrade
|
Dividend Per Share | - | - | - | - | 0.500 | - | Upgrade
|
Gross Margin | 45.38% | 42.67% | 39.61% | 42.32% | 47.38% | 47.20% | Upgrade
|
Operating Margin | 3.78% | 1.70% | -1.08% | 4.10% | 12.39% | 10.62% | Upgrade
|
Profit Margin | 0.38% | -2.62% | -8.53% | 2.90% | 7.01% | 5.93% | Upgrade
|
Free Cash Flow Margin | - | -0.02% | -4.88% | -0.13% | 4.55% | 6.33% | Upgrade
|
EBITDA | 1,192 | 767.82 | 311.55 | 983.02 | 2,092 | 1,661 | Upgrade
|
EBITDA Margin | 8.36% | 5.61% | 2.19% | 6.96% | 15.36% | 14.08% | Upgrade
|
D&A For EBITDA | 653 | 535.09 | 465.01 | 403.4 | 404.26 | 408.48 | Upgrade
|
EBIT | 539.22 | 232.73 | -153.46 | 579.62 | 1,688 | 1,252 | Upgrade
|
EBIT Margin | 3.78% | 1.70% | -1.08% | 4.10% | 12.39% | 10.62% | Upgrade
|
Effective Tax Rate | - | - | - | 15.43% | 23.55% | 12.79% | Upgrade
|
Revenue as Reported | 14,396 | 13,807 | 14,273 | 14,237 | 13,700 | 11,893 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.